Lonnel Coats - Net Worth and Insider Trading
Lonnel Coats Net Worth
The estimated net worth of Lonnel Coats is at least $2 Million dollars as of 2024-05-03. Lonnel Coats is the CEO of Lexicon Pharmaceuticals Inc and owns about 914,359 shares of Lexicon Pharmaceuticals Inc (LXRX) stock worth over $2 Million. Lonnel Coats is also the Director of Blueprint Medicines Corp and owns about 0 shares of Blueprint Medicines Corp (BPMC) stock worth over $0. Details can be seen in Lonnel Coats's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Lonnel Coats has not made any transactions after 2023-11-16 and currently still holds the listed stock(s).
Transaction Summary of Lonnel Coats
Lonnel Coats Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Lonnel Coats owns 3 companies in total, including Blueprint Medicines Corp (BPMC) , Lexicon Pharmaceuticals Inc (LXRX) , and Verve Therapeutics Inc (VERV) .
Click here to see the complete history of Lonnel Coats’s form 4 insider trades.
Insider Ownership Summary of Lonnel Coats
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| BPMC | Blueprint Medicines Corp | 2019-08-15 | director |
| LXRX | Lexicon Pharmaceuticals Inc | 2023-11-10 | director & President and CEO |
| VERV | Verve Therapeutics Inc | 2022-08-08 | director |
Lonnel Coats Latest Holdings Summary
Lonnel Coats currently owns a total of 2 stocks. Among these stocks, Lonnel Coats owns 914,359 shares of Lexicon Pharmaceuticals Inc (LXRX) as of November 16, 2023, with a value of $2 Million and a weighting of 100%. Lonnel Coats also owns 0 shares of Blueprint Medicines Corp (BPMC) as of August 15, 2019, with a value of $0 and a weighting of 0%.
Latest Holdings of Lonnel Coats
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| LXRX | Lexicon Pharmaceuticals Inc | 2023-11-16 | 914,359 | 1.71 | 1,558,982 |
| BPMC | Blueprint Medicines Corp | 2019-08-15 | 0 | 107.00 | 0 |
Holding Weightings of Lonnel Coats
Lonnel Coats Form 4 Trading Tracker
According to the SEC Form 4 filings, Lonnel Coats has made a total of 8 transactions in Lexicon Pharmaceuticals Inc (LXRX) over the past 5 years, including 8 buys and 0 sells. The most-recent trade in Lexicon Pharmaceuticals Inc is the acquisition of 90,000 shares on November 16, 2023, which cost Lonnel Coats around $94,500.
According to the SEC Form 4 filings, Lonnel Coats has made a total of 1 transactions in Blueprint Medicines Corp (BPMC) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Blueprint Medicines Corp is the sale of 10,000 shares on August 15, 2019, which brought Lonnel Coats around $824,000.
Insider Trading History of Lonnel Coats
- 1
Lonnel Coats Trading Performance
GuruFocus tracks the stock performance after each of Lonnel Coats's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Lonnel Coats is 38.16%. GuruFocus also compares Lonnel Coats's trading performance to market benchmark return within the same time period. The performance of stocks bought by Lonnel Coats within 3 months outperforms 5 times out of 10 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Lonnel Coats's insider trading performs compared to the benchmark.
Performance of Lonnel Coats
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 14.46 | | | | | |
| Relative Return to S&P 500(%) | 11.4 | | | | | |
Lonnel Coats Ownership Network
Lonnel Coats Owned Company Details
What does Blueprint Medicines Corp do?
Who are the key executives at Blueprint Medicines Corp?
Lonnel Coats is the director of Blueprint Medicines Corp. Other key executives at Blueprint Medicines Corp include Principal FAO Michael Landsittel , director & CEO & President Jeffrey W. Albers , and Principal Accounting Officer Ariel Hurley .
Blueprint Medicines Corp (BPMC) Insider Trades Summary
Over the past 18 months, Lonnel Coats made no insider transaction in Blueprint Medicines Corp (BPMC). Other recent insider transactions involving Blueprint Medicines Corp (BPMC) include a net sale of 175,899 shares made by Jeffrey W. Albers , a net sale of 11,217 shares made by Christopher K. Murray , and a net sale of 26,744 shares made by Michael Landsittel .
In summary, during the past 3 months, insiders sold 118,534 shares of Blueprint Medicines Corp (BPMC) in total and bought 0 shares, with a net sale of 118,534 shares. During the past 18 months, 300,807 shares of Blueprint Medicines Corp (BPMC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 300,807 shares.
Blueprint Medicines Corp (BPMC)'s detailed insider trading history can be found in Insider Trading Tracker table.
Blueprint Medicines Corp Insider Transactions
Lonnel Coats Mailing Address
Above is the net worth, insider trading, and ownership report for Lonnel Coats. You might contact Lonnel Coats via mailing address: 8800 Technology Forest Place, The Woodlands Tx 77381.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
